Showing posts with label funding. Show all posts
Showing posts with label funding. Show all posts

Monday, April 27, 2009

Mixing Ingredients For Success

I think it’s important to appreciate the relationship between three key ingredients in any business: enterprise, innovation and finance. An entrepreneur is a person who operates and assumes the risk for a business venture. Innovation which is the process of making improvements by introducing something new. Every successful company needs combination of these two ingredients, plus a healthy dollop of money. And they need to be mixed!

Getting these three ingredients to work together is the key to success. Each needs better understand each other’s language, motivations and values. This is doubly important in the UK where VCs and equity funders traditionally have an accountancy background compared to their more tech savvy USA counterparts.

Initiatives like the Enterprise Fellowship Scheme funded by Yorkshire Forward is a sterling example of how researchers can get some entrepreneurial DNA spiced into them without compromising their academic integrity. Having a potential commercial outcome in mind from the outset can inform the research as much as that all important journal publication. At Connect, we are increasingly involving academics on our company assessment panels to help assess technical innovations coming from the private sector.

Great companies are built by teams that bringing together money, management and ideas. You need a critical mass of these components and the infrastructure to connect them. People are the ultimate technology transfer agent and commercialisation is a ‘Contact’ sport. And organisations like Connect can provide an important mechanism for catalyzing and promoting this reaction, linking entrepreneurs and innovators with the resources they need to succeed.

Our upcoming Connect Investment Forum provides a key platform for promoting this interaction. We also provide online introductions through MyDealMaker and publish a periodic Investor Bulletin to bring companies on our radar screen to the attention of potential investors.

Thursday, March 13, 2008

Gender-Based Finance

Budget 2008 introduces a package of measures to support small businesses access the finance and resources they need to start up and grow. What caught my eye was the announcement of a new £12.5M capital fund to invest in businesses started by women.

I have trawled the HMRC website to try to find out more about how is that going to work but to no avail. Most businesses are built around a team, not one individual. Can men be part of the management team and have any equity share? What if other outside investors gets involved that have more testosterone (chemical structure shown) than they should?

Plenty of companies relocate to access geographically-constrained finance. Are we now going to see the first sex change to gain funding? Surely there are better ways to encourage female entrepreneurs than this. Creating an ecosystem that nurtures and support people seeking to build a business would be a better use of this money than distorting the market in this way. Investors should be backing bright ideas and good people, not worrying about genetic makeup.

Friday, February 08, 2008

Nothing Ventured...

Deirdre Bounds gave a passionate talk at the Venturefest Yorkshire 2008 dinner. As a former stand up comic I expected a few more laughs, but she mainly focused on her journey from 'bedsit to boardroom'.

What was her take home message? Well mainly that if you have got an idea just do it, even if no one around you gets it: if you believe in yourself you can succeed in realising your vision. This was rather at odds with Ajaz Ahmed's talk earlier in the day where he was lamblasting government support agencies for backing 'lame duck' ideas that were destined to fail and that people shouldn't be given 'false hope' that they can become 'supermodels'

I must admit to being more with Deirdre on this one. Sure, we need to screen out the ideas and people that are just plain daft and applaud the ones that are sure fire winners (because they, like Deirdre, will fly without any outside help or an outside investor getting a slice of the action). But in the beauty contest that is innovation and enterprise, the winners and losers will sort themselves out in the marketplace (think dancefloor, not stage). Out there it's execution and the audience vote that counts: the wisdom of crowds, not the opinion of experts. In my experience, most good ideas start off looking pretty ugly or just plain daft to conventional eyes. As Deirdre says 'We need to encourage weird'.

Saturday, January 26, 2008

Something for Nothing...

Surely the best deal is the one that generates the greatest return on investment. But those apparently in the know keep telling me Proof-of-Concept funds can't make money. But aren't business angels tying to make money and they are managing their own mini -POC fund. If you can make money on a small scale why, I ask, doesn't this scale up?

If you watch Dragon's Den they are always looking for the largest percentage of equity they can get. But 100% of nothing is still nothing, so you could say that it doesn’t matter whether you get 20% or 40% (this has been the argument of a few VCs who seem to cut much more generous offers than the dragons do) given most will fail.

Surely the point is that for the 1 in 10 early stage deals that really do fly, what percentage you have of that one is very much the differentiator when you come to analysing the overall portfolio returns. Is the problem then that larger funds just aren't prepared to get down and dirty with regards to valuations whereas individual business angels are very much focused on getting more for less? The fact that an early stage business will often get the cheapest money it's going to get i.e. grant funding followed immediately by the most expensive in terms of equity investment does little to help the situation!

Thursday, January 10, 2008

Selling Equity: The First Resort

Selling equity in your business is hard, expensive and like oil, it's not a renewable resource. If you have any other easier or cheap alternative source of financing your business you should take it, but equally if you don't, do you really want to miss out on realising your dreams by preciously holding on to it - which is what far too many people do.

In business, a smaller slice of a bigger pie is invariably bigger than 100% of nothing. But therein lies the rub: An equity investor is looking to invest in a business that is scalable i.e. it can grow beyond being a 'lifestyle' business. So if you are serious about changing the world, gaining an equity investment should be your first and highest priority, as this is your only realistic means taking your business to the next level.

Our experience is that you can't be too prepared and our investment readiness process is invaluable in putting the foundations in place on which you can confidently pitch for the investment you need. How much is usually the next question. The reality is you need to find a balance between seeking too little and too much. This is where a business plan with realistic cash flow projections comes in. You need to have enough equity funding to meet you maximum cash requirement to get your product or service to market. Once you start selling something and you (just) need working capital, your funding options are cheaper & more varied: Factoring, overdraft, loans, etc.

Thursday, January 03, 2008

New Year Predictions

OK here goes:

Connect Yorkshire helps even more companies get investment ready and pitch for investment through its flagship investment forums, investment challenges and business plan competitions.

The rest of the Northern Way embrace the Connect model and it is rolled out in the North East and North West.

An online community of best practise, participation and support develops that brings together entrepreneurs with the resources to they need to help them succeed that extends beyond our traditional geographic boundary and the Web 2.0 community.

Yorkshire Forward announces a region-wide investment fund as a follow on for Partnership Investment Finance and the South Yorkshire Investment Fund that incorporates a much needed seedcorn element.

Component-based, service-oriented applications finally take centre stage with Web Mashups and loosely-coupled applications 'Web 2.0' increasingly replacing the monoliths of the past.

Connect launches its 'Springboard' initiative to help early stage propositions get their business plans into shape.

I finally access and use a Web site in a meaningful way through my mobile phone.

One can but dream...Happy New Year!

Monday, October 08, 2007

Online Research Versus Legwork

There seems to be an increasing trend to research opportunities online before expending too much physical effort evaluating the options. Who last went looking around a new neighbourhood looking for houses, rather than first having a trawl of Rightmove? Tesco have just launch a new comparision website to compete with the likes of MoneySupermarket. So there must be money in them there hills. And with MyDealMaker debuting, even venture capitalists and angel investors can get in on the act and search for entreprenurs with big ideas looking for funding that meet their search criteria.

Where will it all end? In the lead, not supprisingly, is Formula One. Car design is apparently moving from using computer simulation to validate an hypothesis to ab initio models where nothing physical is made until the computer says yes. Drug design has similarly embraced the idea that sampling chemical space is best done virtually before that expensive step of synthesising anything is taken and anyone gets their hands dirty.

Who, thirty years ago, would have believed that computers would be used for screening potential dates/mates before 'pressing the flesh'! And if you had said we would all be texting like mad, rather than videoconferencing by now you would have been laughed out of the room. As the BT futureologist at a recent YSTN event commented, maybe we should be employing more phycologists to help design new products, rather than leaving this entirely to the technologists!

Tuesday, September 25, 2007

Fail Fast, Fail Early

Not the most inspiring of titles, but ask any medicinal chemist what the chances of his or her lead molecule making it through clinical trials and it's about one in ten (and falling). And no matter what anyone tells you, no one knows which development projects will fail when on the journey from the lab to your bathroom cabinet. Yes, that pill you pop for hay fever or hypertension is the result of a whole lot of great science and one big dose of good fortune.

The development strategy of big pharma embraces this fact as they seek to spend the least amount of money on the ones that don't make it. Fail fast, fail early is their mantra. So why don't they run tests in parallel (assuming it's ethical and legal) and speed up the process? Unfortunately, with these odds history and a few calculations in Excel tells you its a mug's game to try to rush perfection to much. What you need is a development pipeline (which is what equity analysts sweat about as the last blockbuster goes off patent) and then you can play the numbers game and be reasonably patient.

But wait, what about small guy who just has one or two throws of the dice and mix in a doze of commercial reality that their wonder drug or medical device has a limited market potential? And what if they don't have the luxury of funding their development from previous successes? Then they have to raise funding from VCs who don't want to wait a decade to see a return and even then the market potential may not give sufficient returns to make the investment add up financially. This is the problem facing many Healthcare Technology companies and it ain't easy to beat the numbers.

Complaining about the short time horizon and greediness of VCs is about as useful as trying to rush a product through clinical trials (and by that I mean spend more money on failures faster). It just isn't that productive. So what is the answer to this connundrum? The obvious answer is to licence more things earlier and accept a smaller slice of the pie if they make it through to market - which is what most smaller biotechs do. Alternatively, you can find a friendly source of development funds that is prepared to wait for a return and see your project through from cradle to grave - it's called working for Glaxo! But is there a third way?

Wednesday, January 31, 2007

The Business of Innovation

Attended this event at the National Media Museum, Bradford, organised by Yorkshire Forward and the Centres for Industrial Collaboration. The Yorkshire Science debate was interesting and reminded us once again about the lack of Proof-of-Concept funding in the region to help fledgling technology innovators. The difference between innovation and enterprise (entrepreneurship) was interesting and emphasised the need for teamwork - to get both skills in one person was rare. And the perennial issue of failure (or fear of it) was raised from the floor and from the panel. The theme that if we are not failing often enough we are not taking enough risks was an interesting if provocative one.

Thursday, November 02, 2006

Points Win Prizes

Funding comes in all shapes and sizes. Maybe one for the adventurous, but the Genomics X Prize has just been announced that promises $10M for the first successful sequencing of 100 human genomes in 10 days. This kind of high-throughput (low cost) genetic profiling is a prerequisit to usher in the era of personalised medicines.

More bite-size prize challenges can be found on the Innocentive web site that seeks to match up scientific problems of commercial worth with 'solvers'. Only problem is that if you solve one of the challenges you have to sign over the IP rights...like any fund raising you have to give some to get some!

Tuesday, October 03, 2006

The World's Largest Seed Capital Fund

A Private Members Bill sponsored by Kitty Ussher gets its second reading this autumn which calls on the Government to implement a framework similar to the USA's Small Business Innovation Research Programme, which ensures that 2.5pc of the Federal R&D budget (worth $1.8billion in 2006) goes to young technology firms.

David Connell from Cambridge University's Centre for Business Research has written a report called "Secrets of the World's Largest Seed Capital Fund" and is leading the campaign for bringing such an initiative to the UK. Clearly, it could play a major role in helping to fund early stage technology businesses and give them a slice of the R&D pie that has traditionally gone exclusively to the Universities and larger research organisations. Improved access to proof-of-concept funding and seedcorn capital is needed to help nurture early stage science and technology companies and Connect Yorkshire applauds this initiative.

On a related theme, Red Planet Capital is a non-profit organisation that is establishing a strategic $75M venture capital fund for NASA. The purpose of the fund is to provide NASA earlier and broader exposure to emerging technologies. It is designed to promote the future availability of technologies with both government and commercial applications that can meet NASA's future mission requirements. The effort signifies the administration's commitment to creative approaches for promoting innovation in pursuit of America's space agenda.

Hot on its heals, is the MOD seeking to inspire innovators from across Britain to bid for a slice of £10M to develop their ideas further to help meet key defence challenges. See www.ideas.mod.uk.

Friday, July 07, 2006

Lack of Proof of Concept Funding

We need more people starting up knowledge-based businesses. We have to acknowledge success if far from certain. There will be failures: unless there are we, as a region, are being too conservative in our thinking. However, with the help of organisations like Connect we can load the dices in favour of success and avoid the mistakes of the past. Enterprise and innovation is not a one way street. We need good technology that matches to a market need. All too often an idea misses the mark; aligning the technology with an addressable market need is what innovation is all about. Connecting entrepreneurs with the resources they need to nurture their initial seed of an idea until it reaches sustainability is a key part of the equation.

A key part of this that is lacking in the Yorkshire region is Proof of Concept funding. If we look to our neighbours, the North East has a £10M fund, set up to stimulate the growth of new technology companies. The North West similarly has access to the Rising Stars fund that backs early stage companies. These funds typically put £25-60K into a company at inception, with the option to invest further if the idea is shown to have legs. What access do would-be entrepreneurs have to funding at this level in the Yorkshire region? The reality is very little, but this is a key part of the innovation landscape.

Some pump priming is needed if we expect the region to generate sustainable technology businesses further down stream. The reality is that 3 out of 4 of these investments may not generate a return, but the ones that do will make up for the others - or that is how it should be if we are finding the correct balance between risk and reward.

Friday, April 07, 2006

The Enterprising Enterprise Show

For anyone thinking of starting up a business The Enterprise Shows are well worth a visit! I attended the Leeds event last Saturday and was extremely impressed with the amount of information immediately accessible to budding entrepreneurs.

Talk about time saving, in one place you can get instant advice on your business plan, talk to banks about financial issues, listen to real life experiences of business success, learn about funding, finding investment, insurance, patents, trading standards…………………. the list goes on. It certainly helps cut through the mass of support now available to new businesses and you can soon work out what’s relevant to you.

The HM Revenue and Customs team had a queue of people waiting to speak to them most of the day, who would have thought VAT was so interesting!

Tuesday, March 07, 2006

Brains must earn a crust too

We produce some of the best research academics in the world, yet their knowledge is locked away within the hallowed halls of academia.

The UK economy would benefit hugely from the innovation and technology which universities produce, but despite noises from central government about business and academia working together, the vast majority of academic revenue remains untapped.

Yorkshire has 12 higher education establishments - some with world class research and teaching credentials. Almost 80 per cent of the departments at the University of York, for example, were given 5 or 5* ratings fro research, meaning research was of international importance. Three of our universities are within the top 30 in the UK.

Why then is the Yorkshire and Humber region languishing in 8th place for innovation in the UK? Only the North East, Northern Ireland and Wales fare worse.

The answer is that the mindset behind attributing and recognising academic excellence is wrong. Currently the Research Assessment Review is carried out every four to five years. The process involves a panel of 685 people reviewing almost a quarter of a million pieces of research from 56,000 academics.

On the back of this huge bureaucratic exercise approximately £1 billion of research funding is allocated to UK universities. Incredibly nowhere is a university’s contribution to business or the economy mentioned.

In 2002 the government’s Investing in Innovation report stated that: “In an increasingly knowledge-driven global economy invention and innovation are critical to Britain’s long-term competitiveness. This requires a virtuous circle of innovation: from the very best research in science, engineering and technology in universities and science labs to the successful exploitation of new ideas, new science and new technologies by businesses.”

Currently the allocation of research grants appears to miss half of this “virtuous circle”. Yes, it assesses the quality of research, but it takes no account of “successful exploitation”.

In common with other sectors, higher education is subjected to league tables which institutions desperately try to climb. Research ratings play an important part along with other factors such as teaching quality assessment and entry standards.

However if we look at how university’s are ranked by employers the results are strikingly different from the usual research/teaching quality league tables published in five of the national broadsheets – the Daily Telegraph, Financial Times, The Times, and the Sunday Times.

For example the University of York is ranked from second (in the Daily Telegraph) to eighth (in the Financial Times). However when surveyed by 200 firms which regularly recruit graduates York’s ranking slips to twenty-ninth.By contrast, Leeds University is ranked between twenty–second (in the Telegraph) and thirty-fifth (in the Times); when it comes employers Leeds is ranked ninth in the UK.

Of course within Yorkshire there have been significant, if not fundamental, steps towards improving the situation. Three of our university’s have organisations which carry out a commercialisation function. Leeds University works with Techtran and IP2IPO. Sheffield University has two organisations - SUEL (Sheffield University Enterprises Ltd) and Bio Fusion, which is tasked with commercialising the IP output from the Biology and Chemistry departments. York, which is relatively new to the technology transfer game, has employed business development officers to help with its commercialisation activity.

SUEL has spun out 40 companies and created 60 external jobs. Techtran has also had its share of success with high profile spinouts including Syntopix and Potopharmacia under its belt. In York the Science City partnership between the university and the city council has created 60 companies and 2,600 jobs in the wider science and technology sector.

Other organisations such as Connect Yorkshire are also playing their part in helping young technology companies grow and become successful businesses contributing to the regional and national economies.

There have been some spectacular successes. BioFusion, spun out of Sheffield University, floated on AIM and raised £8.2 million. Bradford Particle Design, started by Dr Gwyn Humphreys of Bradford University in 1995 was acquired by Inhale Therapeutic Systems for £137m. Molecular Skincare, founded by Dr Simon Ward of Sheffield University, was brought by York Pharma for around £5.5 million.

These are fantastic achievements, but they are achieved despite the pervading culture of academic institutions and not because of it. To fulfil our national and regional potential we need fundamental changes in how we evaluate our universities. We must not be squeamish - the rest of the UK runs on capitalist money making principals and we cannot afford for our top brains not to.